Long Meng

562 total citations
31 papers, 379 citations indexed

About

Long Meng is a scholar working on Pulmonary and Respiratory Medicine, Geriatrics and Gerontology and Oncology. According to data from OpenAlex, Long Meng has authored 31 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Geriatrics and Gerontology and 7 papers in Oncology. Recurrent topics in Long Meng's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Long Meng is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). Long Meng collaborates with scholars based in China, United States and Belgium. Long Meng's co-authors include Shusen Sun, Feng Qiu, Yuntao Jia, Jing Huang, Jing Huang, Bing Yang, Zhigang Luo, Hong Chen, Yongfei Chen and Jiadan Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and IEEE Transactions on Industrial Informatics.

In The Last Decade

Long Meng

27 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Long Meng China 13 81 78 68 47 47 31 379
Pauline Bosco‐Lévy France 13 63 0.8× 23 0.3× 61 0.9× 31 0.7× 36 0.8× 31 399
Rolin L. Wade United States 15 61 0.8× 45 0.6× 86 1.3× 105 2.2× 34 0.7× 80 637
Mary E. Ritchey United States 13 89 1.1× 78 1.0× 91 1.3× 39 0.8× 36 0.8× 32 564
Cristina Aguilera Spain 10 64 0.8× 106 1.4× 33 0.5× 79 1.7× 62 1.3× 54 690
Ayad K. Ali United States 10 43 0.5× 14 0.2× 38 0.6× 55 1.2× 45 1.0× 33 407
Natsumi Ueda Japan 13 35 0.4× 24 0.3× 56 0.8× 25 0.5× 111 2.4× 24 468
Susan Andrade United States 9 30 0.4× 74 0.9× 74 1.1× 41 0.9× 30 0.6× 12 519
Hélène Théophile France 15 42 0.5× 56 0.7× 52 0.8× 71 1.5× 171 3.6× 28 602
Michele Fusaroli Italy 13 155 1.9× 19 0.2× 184 2.7× 30 0.6× 67 1.4× 45 562
Anat Fisher Canada 11 45 0.6× 28 0.4× 22 0.3× 85 1.8× 33 0.7× 32 451

Countries citing papers authored by Long Meng

Since Specialization
Citations

This map shows the geographic impact of Long Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Meng more than expected).

Fields of papers citing papers by Long Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Meng. The network helps show where Long Meng may publish in the future.

Co-authorship network of co-authors of Long Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Long Meng. A scholar is included among the top collaborators of Long Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long Meng. Long Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Haofeng, Long Meng, Zhenkun Sun, et al.. (2026). Radiosynthesis and Evaluation of 18 F-Labeled Deuterated Radioligand for Positron Emission Tomography Imaging of Cholesterol 24-Hydroxylase. ACS Medicinal Chemistry Letters. 17(2). 538–546.
2.
Meng, Long, et al.. (2024). Capecitabine-associated gastrointestinal ulceration, haemorrhage, and obstruction: a pharmacovigilance analysis based on the FAERS. Frontiers in Pharmacology. 15. 1412938–1412938. 1 indexed citations
3.
Liu, Yang, et al.. (2024). PIL-MDRS: Physical Intrusion Localization Based on Multidevice Reflection Signals in ICS. IEEE Transactions on Industrial Informatics. 21(3). 2432–2441.
4.
Xue, Lifen, et al.. (2024). Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system. International Journal of Clinical Pharmacy. 46(2). 480–487. 7 indexed citations
5.
Meng, Long, et al.. (2022). Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database. Journal of Clinical Sleep Medicine. 18(9). 2229–2235. 3 indexed citations
6.
Huang, Yu, Rui Long, Juan Li, et al.. (2022). Effects of 4-DAMP on allergic rhinitis in guinea pigs and its potential mechanism. Annals of Translational Medicine. 10(14). 774–774. 1 indexed citations
7.
Huang, Jing, Yanni Cao, Qingxia Zhang, et al.. (2022). Anaplastic lymphoma kinase tyrosine kinase inhibitors associated gastrointestinal obstruction, perforation, and ulceration: an analysis of the FDA adverse event reporting system database (FAERS). International Journal of Clinical Pharmacy. 44(4). 993–1003. 9 indexed citations
8.
Meng, Long, et al.. (2021). Drug‐Related Problems among Hospitalized Surgical Elderly Patients in China. BioMed Research International. 2021(1). 8 indexed citations
9.
Meng, Long, Bing Yang, Feng Qiu, et al.. (2021). Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database. Frontiers in Medicine. 8. 594043–594043. 14 indexed citations
10.
Sun, Yu, et al.. (2020). A Novel MYH9-RET Fusion Occurrence and EGFR T790M Loss as an Acquired Resistance Mechanism to Osimertinib in a Patient with Lung Adenocarcinoma: A Case Report. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Huang, Jing, Long Meng, Bing Yang, et al.. (2020). Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System. Scientific Reports. 10(1). 4803–4803. 57 indexed citations
12.
Huang, Jing, Yuntao Jia, Shusen Sun, & Long Meng. (2020). Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system. BMC Pharmacology and Toxicology. 21(1). 68–68. 39 indexed citations
13.
Meng, Long, et al.. (2019). Improving Behaviour in Schools: Guidance Report. Digital Education Resource Archive (University College London). 3 indexed citations
14.
Zhang, Sha, Long Meng, Jiadan Yang, Ling Luo, & Feng Qiu. (2018). Study on Attitudes towards Deprescribing among Elderly Patients with Chronic Diseases in Several Communities of Chongqing. Zhongguo yaofang. 1408–1411. 1 indexed citations
15.
Zhang, Sha, Long Meng, Feng Qiu, Jiadan Yang, & Shusen Sun. (2018). Medication-related risk factors associated with health-related quality of life among community-dwelling elderly in China. Patient Preference and Adherence. Volume 12. 529–537. 14 indexed citations
16.
Meng, Long, et al.. (2018). Electronic medication reconciliation in hospitals: a systematic review and meta-analysis. European Journal of Hospital Pharmacy. 25(5). 245–250. 12 indexed citations
17.
Yang, Jiadan, Long Meng, Yü Liu, et al.. (2018). Drug-related problems among community-dwelling older adults in mainland China. International Journal of Clinical Pharmacy. 40(2). 368–375. 16 indexed citations
18.
Meng, Long, Yun Fang, Yongfei Chen, Huaijun Zhu, & Rui Long. (2014). High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis. Journal of Chemotherapy. 27(4). 213–220. 14 indexed citations
19.
Chen, Yongfei, Long Meng, Hua Shao, & Feng Yu. (2012). Aliskiren vs. other antihypertensive drugs in the treatment of hypertension: a meta-analysis. Hypertension Research. 36(3). 252–261. 22 indexed citations
20.
Zhang, Baijiang, et al.. (2011). A Meta Analysis on Relationship between GSTP1 Ile105Val Genetic Polymorphisms and Lung Cancer Risk. Zhongliu fangzhi yanjiu. 38(11). 1311–1315. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pauline Bosco‐Lévy Breakdown of academic impact, for papers by Rolin L. Wade Breakdown of academic impact, for papers by Mary E. Ritchey Breakdown of academic impact, for papers by Cristina Aguilera Breakdown of academic impact, for papers by Ayad K. Ali Breakdown of academic impact, for papers by Natsumi Ueda Breakdown of academic impact, for papers by Susan Andrade Breakdown of academic impact, for papers by Hélène Théophile Breakdown of academic impact, for papers by Michele Fusaroli Breakdown of academic impact, for papers by Anat Fisher
Rankless by CCL
2026